Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk’s chief of staffs to leave

Company reduces number of executives from seven to six
Lise Kingo, Novo Nordisk

Novo Nordisk has decided to reduce the number of its executives from seven to six resulting in the departure of its chief of staffs Lise Kingo.

Kingo's responsibilities will be split among the remaining executives, including Lars Fruergaard Jørgensen, Jakob Riis and CEO Lars Rebien Sørensen.

Sørensen said: "I would like to thank Lise for her many contributions to Novo Nordisk during her impressive career in the company. Of special note is her leadership in driving the company's strategy within sustainable development, corporate branding and public affairs, which has earned Novo Nordisk recognition as a respected global business.”

Kingo joined Novo in 1988 and worked her way up the ranks, being appointed senior VP in 1999 and then as executive VP and chief of staffs in 2002. Her other roles include chair of the board of Steno Diabetes Center and member of the board of Grieg Star Group.

27th November 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics